Drug Shortage Report for NRA-SERTRALINE
| Report ID | 121639 |
| Drug Identification Number | 02488434 |
| Brand name | NRA-SERTRALINE |
| Common or Proper name | SERTRALINE |
| Company Name | NORA PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | SERTRALINE |
| Strength(s) | 25MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | N06AB |
| ATC description | ANTIDEPRESSANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-08-01 |
| Estimated end date | 2020-10-31 |
| Actual end date | 2020-12-17 |
| Shortage status | Resolved |
| Updated date | 2021-03-17 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1565 LIONEL-BOULET BLVD. VARENNES, QUEBEC CANADA J3X 1P7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2021-03-17 | French | Compare |
| v7 | 2021-03-17 | English | Compare |
| v6 | 2020-08-03 | French | Compare |
| v5 | 2020-08-03 | English | Compare |
| v4 | 2020-08-03 | English | Compare |
| v3 | 2020-08-03 | French | Compare |
| v2 | 2020-08-03 | English | Compare |
| v1 | 2020-08-03 | English | Compare |
Showing 1 to 8 of 8